This year marks the 27th joint meeting, where all groups involved share a common interest in familial and population-based cancer.
FAC 2026 provides a forum to develop and discuss new research findings, clinical trials and implementation of technologies about families with multiple cases of breast, ovarian, prostate, endometrial, melanoma, sarcoma, leukaemia, colorectal cancers and the genetic risks associated with childhood cancers.
